Takeda Pharmaceutical
TAK
18.37
+0.27
+1.49%
Takeda Pharmaceutical
US · TAK
#400 by market cap
Listed 1970
18.37
+0.27
+1.49%
Live - 5344 symbols - heartbeat 557s ago
· 2026-10-08 07:37
Pre-market
18.37
0.00%
After-hours
18.37
0.00%
Overnight
18.34
-0.16%
- Market cap
- 58.68B
- P/E (TTM)i
- -55.67
- P/Bi
- 1.23
- EPSi
- -0.31
- Div yieldi
- 3.26%
- 52W posi
- 88%
Reader sentiment
Are you bullish or bearish on TAK?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 1 analysts
Buy
Avg price target
42.99 +134.0%
Price target rangecurrent 18.37
Low42.99
Avg42.99
High42.99
Buy 100%
Hold 0%
Sell 0%
Recent ratings (8)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-14 | BofA Securities | -- | BUY | 42.99 |
| 2026-08-13 | BofA Securities | -- | BUY | 44.21 |
| 2026-08-06 | BofA Securities | -- | BUY | -- |
| 2026-07-30 | BofA Securities | -- | BUY | 19.00 |
| 2026-06-04 | TD Cowen | -- | BUY | 21.00 |
| 2026-03-30 | TD Cowen | -- | BUY | 21.00 |
| 2026-01-29 | TD Cowen | -- | BUY | 18.00 |
| 2025-11-21 | TD Cowen | -- | BUY | 18.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
D+
Momentum strategy signal
Hold
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2027/Q2 | 2026-10-29 | -- | -- | -- |
| 2027/Q1 | 2026-07-30 | -- | ±5.84% | -2.82% (in line) |
| 2026/Q4 | 2026-05-13 | -- | ±10.35% | +1.34% (in line) |
| 2026/Q3 | 2026-01-29 | -- | ±6.06% | +2.88% (in line) |
| 2026/Q2 | 2025-10-30 | -- | ±12.71% | -3.92% (in line) |
| 2026/Q1 | 2025-07-30 | -- | ±7.57% | -5.03% (in line) |
| 2025/Q4 | 2025-05-08 | -- | ±5.31% | -5.25% (in line) |
| 2025/Q3 | 2025-01-30 | -- | ±5.26% | +2.93% (in line) |
| 2025/Q2 | 2024-10-31 | -- | ±10.15% | +0.36% (in line) |
| 2025/Q1 | 2024-07-31 | -- | -- | +1.69% |
| 2024/Q4 | 2024-05-09 | -- | ±12.11% | +2.37% (in line) |
| 2024/Q3 | 2024-02-01 | -- | ±4.11% | -1.51% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:37:49 · For reference only, not investment advice and not tailored to your situation.